Earningsreport

Q1/2024 12/31/2023 EPS -0.060 ZacksConsensus 0.130 ActVsEst (0.190) - Miss

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com